Source briefingSeptember 16, 2026Health & Science
Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis: A cross-country validation study

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.
What the source reports
by Tianfang Shao, Mariana R. Neves, Molly Franke, Carole Mitnick, Jennifer Furin, Ted Cohen, Reza Yaesoubi Background Fluoroquinolones (FQs) are a cornerstone of most all-oral, shorter regimens endorsed by the World Health Organization for the treatment of rifampicin-resistant or multidrug-resistant tuberculosis (RR/MDR-TB).
Knowledge of resistance to FQs can help guide regimen selection at the point of care. In settings where rapid testing for FQ resistance is unavailable, prediction models could support treatment decisions by identifying FQ resistance based on patient characteristics observable…
Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.
Source & verification
Primary source: PLOS Medicine · September 15, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

US Tries but Fails to Dilute UN Human Rights Resolutions
US Attempts to Weaken UN Human Rights Resolutions: An Evidence Review What is established In late 2026, during sessions of the United Nations General…

Medical device makers have gotten worse at disclosing when their products harm people, new study finds. The FDA let them.
What is established A recent peer-reviewed study published in The BMJ and reported by the International Consortium of Investigative Journalists (ICIJ) reveals a decline…

EMA/PE/0000181364
What is established The European Medicines Agency (EMA) has granted a decision regarding a paediatric investigation plan (PIP) for vosoritide as of 8 August…